Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
05 June 2024 - 6:01AM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that
management will participate in a fireside chat at the Goldman Sachs
45th Annual Global Healthcare Conference on Tuesday, June 11, 2024
at 8:40 a.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible
through the Investors & Media section of the company’s website
at www.kiniksa.com. A replay of the event will also be available on
Kiniksa’s website within approximately 48 hours after the
event.
About KiniksaKiniksa is a commercial-stage
biopharmaceutical company focused on discovering, acquiring,
developing, and commercializing therapeutic medicines for patients
suffering from debilitating diseases with significant unmet medical
need. Kiniksa’s immune-modulating assets, ARCALYST®, abiprubart,
and mavrilimumab, are based on strong biologic rationale or
validated mechanisms, target a spectrum of underserved
cardiovascular and autoimmune conditions, and offer the potential
for differentiation. For more information, please
visit www.kiniksa.com.
ARCALYST® is a registered trademark of Regeneron
Pharmaceuticals, Inc.
Every Second Counts!
®Kiniksa Investor and Media
ContactRachel Frank(339) 970-9437rfrank@kiniksa.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Sep 2023 to Sep 2024